Results 261 to 270 of about 112,427 (348)
Drug-Induced Fuchs Syndrome With Isolated Oral Involvement: A Rare Case Report. [PDF]
Paudel S +5 more
europepmc +1 more source
C H, Son +8 more
openaire +1 more source
Chronic inflammatory demyelinating polyneuropathy is an autoimmune disorder causing demyelination, leading to distal weakness, sensory loss, and autonomic dysfunction. Immune activation triggers macrophage‐mediated myelin damage and conduction failure.
Ayesha Khan +11 more
wiley +1 more source
Delayed hypersensitivity reactions to taxanes: Clinical presentation and outcomes of post-medication and rapid drug desensitization. [PDF]
Villarreal-González R +6 more
europepmc +1 more source
A Case of Drug-induced Hypersensitivity Syndrome with Severe Stomatitis
Yosuke Fukushima +8 more
openalex +2 more sources
Trimethoprim/Sulfamethoxazole‐Induced Systemic Toxic Epidermal Necrolysis Syndrome: A Case Report
ABSTRACT Trimethoprim/sulfamethoxazole can induce life‐threatening toxic epidermal necrolysis. Early recognition, immediate drug cessation, and multidisciplinary supportive care are critical. Even with aggressive therapy, mortality remains high, and SCORTEN score aids in prognostication.
Qing Wang, Litong Chen, Wen Ye
wiley +1 more source
Hepatopulmonary Syndrome Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease in a Patient With Interstitial Pneumonia and COPD. [PDF]
Inoue S +11 more
europepmc +1 more source
Drug-Induced Hypersensitivity Syndrome: A Literature Review and A Case Report
Krzysztof Gomułka +4 more
openalex +2 more sources
Apolipoprotein A‐I (ApoA‐I), the principal protein of HDL, plays a key role in reverse cholesterol transport, inflammation modulation, and plaque stabilization in atherosclerotic cardiovascular disease. Emerging ApoA‐I–based therapies, including CSL112, enhance cholesterol efflux capacity, though definitive reductions in cardiovascular events remain ...
Awais Habib +6 more
wiley +1 more source
Genetic variation has a significant impact on patients' response to medicines. Variations in important pharmacogenes have been evaluated in several studies and consequently led to international guidelines from clinical pharmacogenomics consortia. However, there are limited examples of these being implemented across the African continent despite the ...
Janine Scholefield +5 more
wiley +1 more source

